Description
Referenced Citations
- Baralt, D., et al. (2020). “Thymosin alpha 1: A comprehensive review of the literature.” World Journal of Clinical Cases, 8(23), 5821-5832. [Online].
Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747025/ - Tao, N., et al. (2023). “Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application.” International Journal of Molecular Sciences, 24(8), 7296. [Online].
Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144173/ - Li, J., et al. (2013). “Thymosin alpha 1: Biological activities, applications and genetic engineering production.” Peptides, 46, 1-8. [Online].
Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115394/ - Costantini, C., et al. (2019). “A Reappraisal of Thymosin Alpha1 in Cancer Therapy.” Frontiers in Oncology, 9, 873. [Online].
Available: https://www.frontiersin.org/articles/10.3389/fonc.2019.00873/full - ChemicalBook. (2024). “Thymosin α1 | 62304-98-7.” [Online].
Available: https://www.chemicalbook.com/ChemicalProductProperty_EN_CB7678989.htm - Costanzo, M., et al. (2021). “Thymosin α1 for prevention of severe COVID-19 in cancer patients.” Pharmacological Research, 163, 105302. [Online].
Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874885/